Riferimento farmaci
Reboxetine
Reboxetine is a medicine in the class central nervous system. It is used for depression.
- Classe del farmaco: Central Nervous System
- Indicato per: depression
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Central Nervous System
- Forme farmaceutiche comuni
- compressa
- Dosaggi comuni
- 4 mg
- Nomi commerciali
- 2
- Paesi e mercati
- 2
Per cosa si usa
Come agisce
Reboxetine is primarily used to treat depression but has also been found useful in the treatment of narcolepsy and panic disorders. Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
The recommended therapeutic dose is 4 mg twice a day (b.i.d.) i.e.8 mg/day administered orally, maximum daily dose should not exceed 12 mg/day.
Gravidanza e allattamento
- Gravidanza
- Unknown No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred.
- Allattamento
- Unknown Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
Effetti indesiderati segnalati
- Dry mouth
- Insomnia
- Constipation
- Decreased appetite
- Dizziness
- Agitation
Chi deve prestare attenzione
- The starting dose in patients with renal or hepatic insufficiency should be 2 mg b.i.d which can be increased based on patient tolerance.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Reboxetine: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Dosing in older adults
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Reboxetine used for?
Reboxetine is a medicine in the class central nervous system. It is used for Depression.
What side effects have been reported with Reboxetine?
Dry mouth, Insomnia, Constipation, Decreased appetite, Dizziness, Agitation.
Can Reboxetine be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred. Breastfeeding: Unknown. Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
What does Reboxetine interact with?
MediHelp does not list a checked interaction for Reboxetine yet. Always tell your pharmacist about every medicine you take.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
